News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Why I'm Wary Of GRAIL And Its Plan To Develop A Cancer Blood Test



1/9/2017 7:24:24 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
Last week, a big biotech company announced that it’s spinning off a smaller company. Illumina is a DNA sequencing giant, and Grail is its ambitious child. Grail aims to spot cancer early by detecting genetic changes in blood of apparently healthy people.

I admire the goal of early cancer detection, but think this a fool’s mission.

Read at Forbes


comments powered by Disqus
Forbes
GRAIL
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES